These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6236122)

  • 1. [Active immunoprophylaxis of type B viral hepatitis].
    Spiga L; Mela GS
    G Clin Med; 1984; 65(5-6):237-49. PubMed ID: 6236122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoprophylaxis of hepatitis B. 4. Identification of risk groups, recommendations for inoculation, new developments].
    Zoulek G; Jilg W; Deinhardt F
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1263-8. PubMed ID: 6224668
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive and active immunoprophylaxis of hepatitis B.
    Seeff LB; Koff RS
    Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210
    [No Abstract]   [Full Text] [Related]  

  • 4. Active hepatitis B immunization with an experimental German vaccine. IV. Reactogenicity studies in healthy adults and in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):456-65. PubMed ID: 6485640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and serological evaluation of preventive vaccination of volunteers of the high risk group with hepatitis B vaccine].
    Brzosko WJ; Laskowski ZK; Bańkowski A; Janicki P; Dabrowa A; Tkacz B; Gall W
    Pol Tyg Lek; 1986 Jul; 41(28):893-5. PubMed ID: 2945170
    [No Abstract]   [Full Text] [Related]  

  • 6. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 7. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B vaccine.
    Eder G; McDonel JL; Dorner F
    Prog Liver Dis; 1986; 8():367-94. PubMed ID: 3520664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vaccination against hepatitis B. Review and prospects].
    Burette A
    Rev Med Brux; 1984 Jun; 5(6):373-83. PubMed ID: 6385192
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Active and passive immunoprevention of hepatitis B in newborn infants with HBsAg-positive mothers].
    Vierucci A; Resti M; Appendino C; Rossi ME; De Martino M; Ulivelli A
    Pediatr Med Chir; 1984; 6(1):35-44. PubMed ID: 6335750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of the problem of viral hepatitis B prophylaxis].
    Golosova TV; Vlasikhina EM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population to hepatitis B vaccination.
    Minuk GY; German GB; Bernstein KN; Fine A; Schroeder ML; Wong WW
    Clin Invest Med; 1994 Feb; 17(1):61-5. PubMed ID: 8174316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome.
    Szajner-Milart I; Zajaczkowska M; Zinkiewicz Z; Borzecka H; Majewski M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):402-8. PubMed ID: 15315023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-hepatitis B vaccination with H B VAX and HEVAC B vaccine. Results after the first 3 doses in 2 different risk groups].
    Panichi G; Pescini A; De Bac C; Taliani G; Pezzella M
    Recenti Prog Med; 1983 Jan; 74(1):27-35. PubMed ID: 6867448
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis B vaccination of hospital personnel].
    Stelling T; van Hattum J; de Gast GC
    Ned Tijdschr Geneeskd; 1984 Sep; 128(37):1753-7. PubMed ID: 6435001
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant hepatitis B vaccine.
    Med Lett Drugs Ther; 1986 Dec; 28(728):118-9. PubMed ID: 2946924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.